US › Healthcare

Alpha Teknova Inc (TKNO)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$5.52+4.15%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$11.1M
Revenue YoY
+13.1%
Net profit
$-4.6M
Profit YoY
+1.9%
EPS
$-0.08
EPS estimate
$-0.09
Net margin
-41.1%

EPS came in at -0.08 against a street estimate of -0.09 — a beat of 11.1%.

Key statistics

Market cap
$284.2M
Forward P/E
0.0
P/B
4.14
Book value
$1.21
EPS (TTM)
$-0.31
52-week high
$6.68
52-week low
$1.91
50-day MA
$5.01
200-day MA
$3.98
Beta
0.68

Analyst view

Analysts rate Alpha Teknova Inc a buy (3 buy, 2 hold, 0 sell out of 5) with an average price target of $9.00.

Shareholding

Insiders
9.32%
Institutions
84.68%

Largest institutional holders

FundStake
Roubaix Capital, LLC3.51%
Royce & Associates, LP1.99%
BlackRock Inc1.34%
Millennium Management LLC0.83%
Vanguard Capital Management, LLC0.82%
UBS Group AG0.61%
Conestoga Capital Advisors, LLC0.59%
Geode Capital Management, LLC0.57%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alpha Teknova Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.